AzTrials
AzTrials

DementiaNCT02549872

Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries

An observational study of Dementia, run by University College, London at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records therefore provide useful information about the diagnosis and prognosis of patients who develop dementia. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Dementia
What is being tested?
This is not an intervention study
How many people
51,000 participants
Where
1 siteUnited Kingdom
Study dates
Sep 2015to Dec 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients registered in English general practices contributing with data to the CALIBER research platform from 1997 onward.

Who may be able to join

  • Patients aged 18 years and over
  • Registered with a participating general practice during the study period
  • Minimum one year of records prior to study entry meeting CPRD data quality criteria
  • Followed on or after 1 January 1997

Who cannot join

  • Patients without recorded gender
  • Less than 1 year of follow-up between study entry and date of administrative censoring

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • London Farr Institute of Health Informatics

    London

Other trials in United Kingdom

About this study

Official title: Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries: a Cohort Study in Linked Electronic Health Records

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records therefore provide useful information about the diagnosis and prognosis of patients who develop dementia.

In this study we will assess the validity of dementia diagnoses in linked primary care, hospital and death records, by examining the timing of important health transitions in patients with recorded dementia, and we will estimate the lifetime risk of recorded dementia in different age and sex groups

Read the detailed description

Dementia is a clinical syndrome with insidious onset that is difficult to diagnose in its earliest stages. Presentation to healthcare depends not only upon the rates of disease progression, but also on social support, recognition by clinicians, and patients' and carers' fear of diagnosis. Maintaining complete follow up in cohorts of patient with dementia is difficult, because patients with dementia are frequently lost to follow up.

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records should therefore provide useful information about the diagnosis and prognosis of patients who develop dementia with minimal loss to follow-up rates and improved completeness of diagnosis.

Demonstrating that patients with recorded dementia have an earlier onset of typical symptoms, functional impairment and death than patients in the general population would support the veracity of diagnosed dementia recorded in electronic health records and its use as an outcome or exposure in cohort studies and for evaluating policy. Previous studies have found that dementia is poorly recorded in routine clinical practice in comparison to face-to-face studies, although this varies by setting and region. However, ascertainment may be improved by examining linked, longitudinal resources. Comparing the lifetime risk of dementia calculated from linked electronic health records with lifetime risks from other sources will also be a useful information to support the use of linked electronic health records in dementia research.

Electronic health records contain information on important health transitions in patients with dementia: from the earliest stage of the illness (depression, anxiety, memory complaints); the development of cognitive impairment that manifest as loss of capacity or missed appointments; and significant functional impairment, with admission to nursing homes or hospital admission. In this study, we will assess the validity of dementia diagnoses in linked primary care, hospital and death records, by examining the timing of important health transitions in patients with recorded dementia, and estimate the lifetime risk of recorded dementia in different age and sex groups.

Conditions
Dementia
Being tested
This is not an intervention study
Keywords
Dementia, Validity, Mortality, Electronic health records
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • This is not an intervention studyOther

    This study is based on the retrospective analysis of linked electronic health records.

Study groups in NCT02549872
Study groupRoleWhat they receive
DementiaPatients with a recorded diagnosis of dementia in primary or secondary care
Receives: Other: This is not an intervention study
Non-dementiaPatients without a recorded diagnosis of dementia in primary or secondary care
Receives: Other: This is not an intervention study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in secondary care

    Measured: 10 years

  2. Factors associated with dementia diagnosis (any type) recording in mortality data only

    These will be estimated from multivariable logistic regression models

    Measured: 10 years

  3. Symptoms associated with subsequent diagnosis of dementia

    These will be estimated from multivariable logistic regression models

    Measured: 10 years

  4. Lifetime risk of dementia (any type)

    Measured: 10 years

  5. Lifetime risk of mortality associated with dementia (any time)

    Measured: 10 years

  6. Factors associated with dementia diagnosis (any type) recording in secondary care only

    These will be estimated from multivariable logistic regression models

    Measured: 10 years

  7. Factors associated with dementia diagnosis (any type) recording in primary care only

    These will be estimated from multivariable logistic regression models

    Measured: 10 years

  8. Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in mortality data

    Measured: 10 years

  9. Proportion of patients with dementia diagnosis (any type) in secondary care that also are recorded in mortality data

    Measured: 10 years

Secondary outcomes (9)
  1. Proportion of patients with Alzheimer's disease in primary care that are also diagnosed in secondary care

    Measured: 10 years

  2. Proportion of patients with vascular dementia in primary care that are also diagnosed in secondary care

    Measured: 10 years

  3. Lifetime risk of Alzheimer's disease

    Measured: 10 years

  4. Lifetime risk of vascular dementia

    Measured: 10 years

  5. Lifetime risk of mortality associated with Alzheimer's disease

    Measured: 10 years

  6. Proportion of patients with Alzheimer's disease in primary care that are also diagnosed in mortality data

    Measured: 10 years

  7. Proportion of patients with Alzheimer's disease in secondary care that are also recorded in mortality data

    Measured: 10 years

  8. Proportion of patients with vascular dementia in primary care that are also recorded in secondary care

    Measured: 10 years

  9. Proportion of patients with vascular dementia in secondary care that are also recorded in mortality data

    Measured: 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionOct 2015 (estimated)
  4. Study completionDec 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
51,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02549872
Sponsor's protocol ID
15_138
Status last verified
Sep 2015
First submitted
3 Sep 2015
Last updated
15 Sep 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Dementia, run by University College, London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in secondary care (time frame: 10 years). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in